Acadian Asset Management’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $942K | Buy |
681,180
+40,848
| +6% | +$56.5K | ﹤0.01% | 993 |
|
|
2025
Q1 | $624K | Buy |
640,332
+168,230
| +36% | +$164K | ﹤0.01% | 1037 |
|
|
2024
Q4 | $613K | Buy |
472,102
+24,509
| +5% | +$31.8K | ﹤0.01% | 1034 |
|
|
2024
Q3 | $1.54M | Buy |
447,593
+29,664
| +7% | +$102K | ﹤0.01% | 816 |
|
|
2024
Q2 | $1.37M | Buy |
417,929
+284,036
| +212% | +$933K | ﹤0.01% | 891 |
|
|
2024
Q1 | $625K | Buy |
133,893
+46,648
| +53% | +$218K | ﹤0.01% | 956 |
|
|
2023
Q4 | $634K | Buy |
87,245
+5,616
| +7% | +$40.8K | ﹤0.01% | 971 |
|
|
2023
Q3 | $984K | Hold |
81,629
| – | – | ﹤0.01% | 856 |
|
|
2023
Q2 | $860K | Sell |
81,629
-2,644
| -3% | -$27.9K | ﹤0.01% | 918 |
|
|
2023
Q1 | $826K | Buy |
84,273
+58,108
| +222% | +$570K | ﹤0.01% | 926 |
|
|
2022
Q4 | $384K | Buy |
+26,165
| New | +$384K | ﹤0.01% | 1115 |
|